abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 101,941 shares, a drop of 46.7% from the February 12th total of 191,363 shares. Based on an average trading volume of 260,083 shares, the short-interest ratio is presently 0.4 days. Currently, 0.2% of the company’s shares are short sold. Currently, 0.2% of the company’s shares are short sold. Based on an average trading volume of 260,083 shares, the short-interest ratio is presently 0.4 days.
abrdn Healthcare Investors Stock Performance
HQH stock traded down $0.35 during midday trading on Thursday, reaching $18.25. The company’s stock had a trading volume of 163,492 shares, compared to its average volume of 212,208. abrdn Healthcare Investors has a 1 year low of $13.77 and a 1 year high of $20.46. The stock has a fifty day simple moving average of $19.19 and a two-hundred day simple moving average of $18.61.
abrdn Healthcare Investors Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, February 20th will be paid a $0.63 dividend. The ex-dividend date of this dividend is Friday, February 20th. This represents a $2.52 annualized dividend and a yield of 13.8%. This is a boost from abrdn Healthcare Investors’s previous quarterly dividend of $0.57.
Institutional Investors Weigh In On abrdn Healthcare Investors
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
See Also
- Five stocks we like better than abrdn Healthcare Investors
- Gilder: Don’t Buy AI Stocks, Do This Instead
- “This AI Giant is About to Go Bust”
- The gold chart Wall Street is terrified of…
- Is Iran Just a Giant Smokescreen?
- Warning: You are not moving fast enough
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
